> = 1000 |
1 |
tumor—hepatocellular carcinoma |
tumor—hepatocellular carcinoma |
cisplatin—doxorubicin |
N/A |
HCC—AFP |
N/A |
> = 1000 |
2 |
tumor—HCC |
tumor—HCC |
bilirubin—aspartate |
N/A |
HCC—TACE |
N/A |
> = 1000 |
3 |
tumor—liver metastasis |
tumor—liver metastasis |
cisplatin—5-fluorouracil |
N/A |
HCC—p53 |
N/A |
> = 1000 |
4 |
cirrhosis—hepatitis |
tumor—hepatoma |
alcohol—ethanol |
N/A |
HCC—VEGF |
N/A |
> = 1000 |
5 |
hepatocellular carcinoma—liver cirrhosis |
cancer—hepatocellular carcinoma |
oxygen—superoxide |
N/A |
HCC—alpha-fetoprotein |
N/A |
<1000 and > = 100 |
1 |
hepatitis—chronic hepatitis |
cancer–HCC |
cisplatin—platinum |
diethylnitrosamine—phenobarbital |
AFP—DCP |
N/A |
<1000 and > = 100 |
2 |
cancer—HCC |
tumor—metastasis |
tyrosine—serine |
tyrosine—serine |
p53—Bcl-2 |
N/A |
<1000 and > = 100 |
3 |
HCC—liver cirrhosis |
cancer—liver metastasis |
5-FU—folinic acid |
3-methylcholanthrene—phenobarbital |
p53—p21 |
N/A |
<1000 and > = 100 |
4 |
HCC—chronic hepatitis |
tumor—liver cirrhosis |
cisplatin—adriamycin |
tyrosine—sorafenib |
insulin—glucagon |
N/A |
<1000 and > = 100 |
5 |
tumor—metastasis |
cancer—colorectal cancer |
cisplatin—CDDP |
gamma-glutamyl—glutamyl |
HCC—IFN |
N/A |
<100 |
1 |
cirrhosis—viral hepatitis |
hepatoma—hepatitis B |
5-FU—uracil |
tyrosine—imatinib |
TACE—RFA |
gamma-glutamyl transpeptidase—alkaline phosphatase |
<100 |
2 |
hepatoma—hepatitis B |
hepatoma—liver cirrhosis |
alcohol—aldehyde |
tyrosine—threonine |
IL-6—IL-10 |
gamma-glutamyl transpeptidase—HCC |
<100 |
3 |
liver cirrhosis—liver cancer |
hepatoma—liver tumor |
glucose—phosphoenolpyruvate |
diethylnitrosamine—glutathione |
VEGF—CD34 |
gamma-glutamyl transpeptidase—AST |
<100 |
4 |
liver metastasis—liver tumor |
hepatoma—breast cancer |
tyrosine—imatinib |
diethylnitrosamine—2-acetylaminofluorene |
p53—Bax |
histone—HCC |
<100 |
5 |
cirrhosis—hepatitis C |
hepatoma—chronic hepatitis |
ethanol—PEIT |
diethylnitrosamine—glucose |
IL-6—TNF-alpha |
histone—HDAC |